WallStSmart

Inspire Medical Systems Inc (INSP)vsMedtronic PLC (MDT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medtronic PLC generates 3791% more annual revenue ($35.48B vs $911.98M). INSP leads profitability with a 16.0% profit margin vs 13.0%. INSP trades at a lower P/E of 10.7x. INSP earns a higher WallStSmart Score of 68/100 (B-).

INSP

Strong Buy

68

out of 100

Grade: B-

Growth: 6.7Profit: 7.5Value: 8.3Quality: 7.3
Piotroski: 3/9Altman Z: 5.12

MDT

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 7.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

INSPUndervalued (+70.1%)

Margin of Safety

+70.1%

Fair Value

$228.38

Current Price

$51.41

$176.97 discount

UndervaluedFair: $228.38Overvalued
MDTSignificantly Overvalued (-255.7%)

Margin of Safety

-255.7%

Fair Value

$24.34

Current Price

$87.89

$63.55 premium

UndervaluedFair: $24.34Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

INSP3 strengths · Avg: 9.3/10
P/E RatioValuation
10.7x10/10

Attractively priced relative to earnings

Altman Z-ScoreHealth
5.1210/10

Safe zone — low bankruptcy risk

Price/BookValuation
1.9x8/10

Reasonable price relative to book value

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$110.62B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

Areas to Watch

INSP3 concerns · Avg: 3.3/10
EPS GrowthGrowth
3.1%4/10

3.1% earnings growth

Market CapQuality
$1.51B3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

MDT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

Comparative Analysis Report

WallStSmart Research

Bull Case : INSP

The strongest argument for INSP centers on P/E Ratio, Altman Z-Score, Price/Book. Profitability is solid with margins at 16.0% and operating margin at 17.1%. Revenue growth of 12.2% demonstrates continued momentum.

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.

Bear Case : INSP

The primary concerns for INSP are EPS Growth, Market Cap, Piotroski F-Score.

Bear Case : MDT

The primary concerns for MDT are EPS Growth.

Key Dynamics to Monitor

INSP profiles as a mature stock while MDT is a value play — different risk/reward profiles.

INSP carries more volatility with a beta of 0.78 — expect wider price swings.

INSP is growing revenue faster at 12.2% — sustainability is the question.

MDT generates stronger free cash flow (2.3B), providing more financial flexibility.

Bottom Line

INSP scores higher overall (68/100 vs 56/100), backed by strong 16.0% margins and 12.2% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Inspire Medical Systems Inc

HEALTHCARE · MEDICAL DEVICES · USA

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. The company is headquartered in Golden Valley, Minnesota.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Want to dig deeper into these stocks?